About Gene Medicin
Gene Medicin is a company based in Seoul (South Korea) founded in 2008. Gene Medicin offers products and services including GM101, GM102, GM103, GM104, and CDMO/CMO Services. Gene Medicin operates in a competitive market with competitors including Jazz Pharmaceuticals, Revolution Medicines, Senti Biosciences, Blueprint Medicines and Syndax, among others.
- Headquarter Seoul, South Korea
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
- Legal Name (주)진메디신
- Jurisdiction Na, Maharashtra, India
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
Not available
-
Investors
Not available
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Gene Medicin
Gene Medicin offers a comprehensive portfolio of products and services, including GM101, GM102, GM103, GM104, and CDMO/CMO Services.
Therapeutic virus targeting specific cancer cells
Advanced virus for cancer treatment applications
Virus variant in development for oncology use
Pipeline product for targeted cancer therapies
Contract development and manufacturing for biotech partners
People of Gene Medicin
Unlock access to complete
Unlock access to complete
Unlock access to complete
Funding Insights of Gene Medicin
Detailed funding history for Gene Medicin
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Gene Medicin
Investment portfolio details for Gene Medicin
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Gene Medicin
Detailed financials for Gene Medicin
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Gene Medicin Comparisons
Peer comparison for Gene Medicin
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Gene Medicin
Gene Medicin operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Jazz Pharmaceuticals, Revolution Medicines, Senti Biosciences, Blueprint Medicines and Syndax, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Novel biopharmaceutical medicines are developed for unmet medical needs.
|
|
| Locked | Locked | Locked |
Cancer therapies are developed using selective pathway inhibitors.
|
|
| Locked | Locked | Locked |
Cell-based therapies for cancer treatment are developed.
|
|
| Locked | Locked | Locked |
Selective kinase inhibitors are developed for genomically defined cancers.
|
|
| Locked | Locked | Locked |
Targeted therapies for cancer treatment are developed.
|
|
| Locked | Locked | Locked |
Small-molecule drugs for cancer treatment are developed via Degronimid platform.
|
Detailed competitors of Gene Medicin
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Gene Medicin
Complete news archive for Gene Medicin
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Gene Medicin
Gene Medicin was founded in 2008.
Gene Medicin is headquartered in Seoul, South Korea.
Chae Ok Yun is the current CEO of Gene Medicin.
Gene Medicin was established in 2008 in Seoul, South Korea, within the biotechnology sector. Anti-cancer gene therapies are developed through a pipeline that includes GM101, which targets malignant melanoma for therapeutic effects; GM102, which addresses proliferation and metastasis in various cancer cells; and GM103, focused on lung cancer inhibition. Technology patents are maintained by the company, with operations centered on gene-based treatments.
Gene Medicin's top competitors include Jazz Pharmaceuticals, C4 Therapeutics and Syndax.
Gene Medicin offers GM101, GM102, GM103, GM104, and CDMO/CMO Services.